Imprese · 09/07/20041 min di lettura
Notice of Approval of Abbreviated New Animal Drug Application; Oxytocin Injection
Traduzione automatica locale · Lingua originale della fonte
Riepilogo
The Food and Drug Administration's Center for Veterinary Medicine (CVM) is providing notice that it has approved an original abbreviated new animal drug application (ANADA) filed by Cross Vetpharm Group, Ltd. The ANADA provides for the veterinary prescription use of oxytocin injectable solution in ewes, sows, cows, and horses. The applicable section of the regulation did not require amendment.